RecruitingNot ApplicableNCT05380401

Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Metabolic Mechanisms Induced by Enteral Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) Supplementation in Preterm Infants


Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment

328 participants

Start Date

Mar 9, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.


Eligibility

Max Age: 36 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Enfamil® DHA & ARA Supplement for Special Dietary Use for people with premature. The study is currently recruiting participants at 7 locations. People eligible for this study include up to age 36 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTEnfamil® DHA & ARA Supplement for Special Dietary Use

Dosage: 60 mg/kg/day of DHA and 120 mg/kg/day of ARA. Route of administration: enteral tube or by oral syringe


Locations(7)

University of California, Los Angeles (UCLA)

Los Angeles, California, United States

Yale New Haven Hospital

New Haven, Connecticut, United States

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

Northwestern University

Chicago, Illinois, United States

Weill Cornell Medicine

New York, New York, United States

University Health System

San Antonio, Texas, United States

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05380401


Related Trials